PodcastRx with Chris Bender - NCCHC Preview Edition!

Topic

News

Chris is talking overweight and obesity management at the Spring Conference on Correctional Healthcare.

Chris is heading to the Spring NCCHC Conference in Louisville, KY to rep Diamond/OPTICS and give a presentation on overweight and obesity management in the correctional setting. As revolutionary weight loss treatments take hold in the community and in the popular consciousness, Chris is seizing on the moment not to just to talk about GLP-1s, but to review weight management as a whole, pharmocologic and non-pharmacologic treatments, special considerations for the corrections environment, and much more. We take a sneak peak at his presentation and talk about what he hopes attendees will take away from it.

Elswhere, we discuss:

The recent approval of Journavx for pain

Expanded Ozempic indication

RSV and Meningococcal vaccine updates

Rapid initiation approval for Sublocade

The elimination of the clozapine REMS program

And in our final trivia capsule segment, Chris highlights how venom from some very nasty beasties has been utilized to treat everything from hypertension to severe chronic pain.

Visit Chris (and Diamond Pharmacy) at the NCCHC Conference- Booth 500!

References/Further Reading:

Into the Clinic Segment:

FDA Approves Novel Non-Opioid Treatment for Moderate to Severe Acute Pain

Suzetrigine: First-in-Class Nonopioid Pain Therapy Is Approved by FDA

Selective Inhibition of NaV1.8 with VX-548 for Acute Pain

SUZETRIGINE (VX-548) PHASE 2 RESULTS IN PAINFUL LUMBOSACRAL RADICULOPATHY

Vertex Announces FDA Approval of JOURNAVX (suzetrigine), a First-in-Class Treatment for Adults With Moderate-to-Severe Acute Pain

FDA approves new indication for Ozempic to lower kidney risks in type 2 diabetes, CKD

FDA Requires Guillain-Barré Syndrome (GBS) Warning in the Prescribing Information for RSV Vaccines Abrysvo and Arexvy

FDA approves GSK’s pentavalent meningococcal vaccine

FDA approves rapid initiation of Sublocade for opioid use disorder

HIGHLIGHTS OF PRESCRIBING INFORMATION: SUBLOCADE

FDA Officially Removes REMS Requirement for Clozapine

Main Discussion:

Obesity Epidemic in U.S. Prison Populations: A Meta-Analysis and Review of the Literature

Weight gain during incarceration: systematic review and meta-analysis

Stress Exposure, Food Intake, and Emotional State

Trivia Capsule:

The life-saving medicines inspired by animals